Advertisement

Virologica Sinica

, Volume 34, Issue 3, pp 253–261 | Cite as

Early Pattern of Epstein-Barr Virus Infection in Gastric Epithelial Cells by “Cell-in-cell”

  • Wenxing Yue
  • Meijuan Zhu
  • Lielian Zuo
  • Shuyu Xin
  • Jing Zhang
  • Lingzhi Liu
  • Shen Li
  • Wei Dang
  • Siwei Zhang
  • Yan Xie
  • Fanxiu Zhu
  • Jianhong LuEmail author
RESEARCH ARTICLE
  • 182 Downloads

Abstract

Epstein-Barr virus (EBV) is an important human dsDNA virus, which has been shown to be associated with several malignancies including about 10% of gastric carcinomas. How EBV enters an epithelial cell has been an interesting project for investigation. “Cell-in-cell” infection was recently reported an efficient way for the entry of EBV into nasopharynx epithelial cells. The present approach was to explore the feasibility of this mode for EBV infection in gastric epithelial cells and the dynamic change of host inflammatory reaction. The EBV-positive lymphoblastic cells of Akata containing a GFP tag in the viral genome were co-cultured with the gastric epithelial cells (GES-1). The infection situation was observed under fluorescence and electron microscopies. Real-time quantitative PCR and Western-blotting assay were employed to detect the expression of a few specific cytokines and inflammatory factors. The results demonstrated that EBV could get into gastric epithelial cells by “cell-in-cell” infection but not fully successful due to the host fighting. IL-1β, IL-6 and IL-8 played prominent roles in the cellular response to the infection. The activation of NF-κB and HSP70 was also required for the host antiviral response. The results imply that the gastric epithelial cells could powerfully resist the virus invader via cell-in-cell at the early stage through inflammatory and innate immune responses.

Keywords

Epstein-Barr virus (EBV) Cell-in-cell infection Gastric epithelial cells Inflammatory response 

Notes

Acknowledgements

This work was supported by the National Key Research & Development Program and National Natural Science Foundations of China (2017YFC1200204, 31670171, 81728011) and Innovation Foundations for Postgraduates of Central South University (2018zzts817).

Author Contributions

JL and FZ designed and guided the study. WY and MZ performed most of the experiments; LZ, SX, JZ, LL, SL, SZ and YX participated in the experiments; WY, MZ and JL analyzed the data. JL and WY wrote and finalized the manuscript. All authors read and approved the manuscript.

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

Animal and Human Rights Statement

The study protocol was approved by the Medical Ethics Review Committees of Xiangya Hospital, Central South University.

Supplementary material

12250_2019_97_MOESM1_ESM.pdf (106 kb)
Supplementary material 1 (PDF 106 kb)

References

  1. Arora N, Alsaied O, Dauer P, Majumder K, Modi S, Giri B, Dudeja V, Banerjee S, Von Hoff D, Saluja A (2017) Downregulation of sp1 by minnelide leads to decrease in hsp70 and decrease in tumor burden of gastric cancer. PLoS ONE 12:e0171827CrossRefGoogle Scholar
  2. Bornkamm GW, Behrends U, Mautner J (2006) The infectious kiss: newly infected b cells deliver epstein-barr virus to epithelial cells. Proc Natl Acad Sci USA 103:7201–7202CrossRefGoogle Scholar
  3. Chakravorty M, Ghosh A, Choudhury A, Santra A, Hembrum J, Roychoudhury S (2004) Ethnic differences in allele distribution for the il8 and il1b genes in populations from eastern india. Hum Biol 76:153–159CrossRefGoogle Scholar
  4. Chen L, Yuan W, Chen Z, Wu S, Ge J, Chen J, Chen Z (2015) Vasoactive intestinal peptide represses activation of tumor-associated macrophages in gastric cancer via regulation of tnfalpha, il-6, il-12 and inos. Int J Oncol 47:1361–1370CrossRefGoogle Scholar
  5. Chen J, Sathiyamoorthy K, Zhang X, Schaller S, Perez White BE, Jardetzky TS, Longnecker R (2018) Ephrin receptor a2 is a functional entry receptor for epstein-barr virus. Nat Microbiol 3:172–180CrossRefGoogle Scholar
  6. Choi SR, Lee SA, Kim YJ, Ok CY, Lee HJ, Hahm KB (2009) Role of heat shock proteins in gastric inflammation and ulcer healing. J Physiol Pharmacol 60:5–17Google Scholar
  7. Chong JM, Sakuma K, Sudo M, Osawa T, Ohara E, Uozaki H, Shibahara J, Kuroiwa K, Tominaga S, Hippo Y, Aburatani H, Funata N, Fukayama M (2002) Interleukin-1beta expression in human gastric carcinoma with epstein-barr virus infection. J Virol 76:6825–6831CrossRefGoogle Scholar
  8. Cohen JI, Fauci AS, Varmus H, Nabel GJ (2011) Epstein-barr virus: an important vaccine target for cancer prevention. Sci Transl Med 3: 107fs107Google Scholar
  9. Dehne N, Fuhrmann D, Brune B (2013) Hypoxia-inducible factor (hif) in hormone signaling during health and disease. Cardiovasc Hematol Agents Med Chem 11:125–135CrossRefGoogle Scholar
  10. Ding L, Li L, Yang J, Zhou S, Li W, Tang M, Shi Y, Yi W, Cao Y (2007) Latent membrane protein 1 encoded by epstein-barr virus induces telomerase activity via p16ink4a/rb/e2f1 and jnk signaling pathways. J Med Virol 79:1153–1163CrossRefGoogle Scholar
  11. Ding Y, Li XR, Yang KY, Huang LH, Hu G, Gao K (2013) Proteomics analysis of gastric epithelial ags cells infected with epstein-barr virus. Asian Pac J Cancer Prev 14:367–372CrossRefGoogle Scholar
  12. Gambhir S, Vyas D, Hollis M, Aekka A, Vyas A (2015) Nuclear factor kappa b role in inflammation associated gastrointestinal malignancies. World J Gastroenterol 21:3174–3183CrossRefGoogle Scholar
  13. Henle G, Henle W, Clifford P, Diehl V, Kafuko GW, Kirya BG, Klein G, Morrow RH, Munube GM, Pike P, Tukei PM, Ziegler JL (1969) Antibodies to epstein-barr virus in burkitt’s lymphoma and control groups. J Natl Cancer Inst 43:1147–1157Google Scholar
  14. Hu TZ, Huang LH, Xu CX, Liu XM, Wang Y, Xiao J, Zhou L, Luo L, Jiang XX (2015) Expressional profiles of transcription factors in the progression of helicobacter pylori‐associated gastric carcinoma based on protein/DNA array analysis. Med Oncol 32:265CrossRefGoogle Scholar
  15. Hwang YS, Jeong M, Park JS, Kim MH, Lee DB, Shin BA, Mukaida N, Ellis LM, Kim HR, Ahn BW, Jung YD (2004) Interleukin-1beta stimulates il-8 expression through map kinase and ros signaling in human gastric carcinoma cells. Oncogene 23:6603–6611CrossRefGoogle Scholar
  16. Lee HW, Lee EH, Kim SH, Roh MS, Jung SB, Choi YC (2013) Heat shock protein 70 (hsp70) expression is associated with poor prognosis in intestinal type gastric cancer. Virchows Arch 463:489–495CrossRefGoogle Scholar
  17. Li L, Zhang Y, Guo BB, Chan FK, Tao Q (2014) Oncogenic induction of cellular high cpg methylation by epstein-barr virus in malignant epithelial cells. Chin J Cancer 33:604–608Google Scholar
  18. Li Y, Long X, Huang L, Yang M, Yuan Y, Wang Y, Delecluse HJ, Kuang E (2016) Epstein-barr virus bzlf1-mediated downregulation of proinflammatory factors is essential for optimal lytic viral replication. J Virol 90:887–903CrossRefGoogle Scholar
  19. Lian S, Xia Y, Ung TT, Khoi PN, Yoon HJ, Kim NH, Kim KK, Jung YD (2016) Carbon monoxide releasing molecule-2 ameliorates il-1beta-induced il-8 in human gastric cancer cells. Toxicology 361–362:24–38CrossRefGoogle Scholar
  20. Liu L, Zhou Q, Xie Y, Zuo L, Zhu F, Lu J (2017) Extracellular vesicles: novel vehicles in herpesvirus infection. Virol Sin 32:349–356CrossRefGoogle Scholar
  21. Lu JH, Tang YL, Yu HB, Zhou JH, Fu CY, Zeng X, Yu ZY, Yin HL, Wu MH, Zhang JY, Li XL, Li GY (2010) Epstein-barr virus facilitates the malignant potential of immortalized epithelial cells: from latent genome to viral production and maintenance. Lab Invest 90:196–209CrossRefGoogle Scholar
  22. Lu Y, Qin Z, Wang J, Zheng X, Lu J, Zhang X, Wei L, Peng Q, Zheng Y, Ou C, Ye Q, Xiong W, Li G, Fu Y, Yan Q, Ma J (2017) Epstein-barr virus mir-bart6-3p inhibits the rig-i pathway. J Innate Immun 9:574–586CrossRefGoogle Scholar
  23. Ludigs K, Parfenov V, Du Pasquier RA, Guarda G (2012) Type i ifn-mediated regulation of il-1 production in inflammatory disorders. Cell Mol Life Sci 69:3395–3418CrossRefGoogle Scholar
  24. Matsusaka K, Funata S, Fukayama M, Kaneda A (2014) DNA methylation in gastric cancer, related to helicobacter pylori and epstein-barr virus. World J Gastroenterol 20:3916–3926CrossRefGoogle Scholar
  25. McColl SR, Roberge CJ, Larochelle B, Gosselin J (1997) EBV induces the production and release of il-8 and macrophage inflammatory protein-1 alpha in human neutrophils. J Immunol 159:6164–6168Google Scholar
  26. McIlwain DR, Berger T, Mak TW (2013) Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 5:a008656CrossRefGoogle Scholar
  27. Morales-Sanchez A, Fuentes-Panana EM (2014) Human viruses and cancer. Viruses 6:4047–4079CrossRefGoogle Scholar
  28. Murata T, Tsurumi T (2014) Switching of EBV cycles between latent and lytic states. Rev Med Virol 24:142–153CrossRefGoogle Scholar
  29. Nemerow GR, Mold C, Schwend VK, Tollefson V, Cooper NR (1987) Identification of gp350 as the viral glycoprotein mediating attachment of epstein-barr virus (ebv) to the ebv/c3d receptor of b cells: sequence homology of gp350 and c3 complement fragment c3d. J Virol 61:1416–1420Google Scholar
  30. Nemerow GR, Houghten RA, Moore MD, Cooper NR (1989) Identification of an epitope in the major envelope protein of epstein-barr virus that mediates viral binding to the b lymphocyte ebv receptor (cr2). Cell 56:369–377CrossRefGoogle Scholar
  31. Ni C, Chen Y, Zeng M, Pei R, Du Y, Tang L, Wang M, Hu Y, Zhu H, He M, Wei X, Wang S, Ning X, Wang M, Wang J, Ma L, Chen X, Sun Q, Tang H, Wang Y, Wang X (2015) In-cell infection: a novel pathway for epstein-barr virus infection mediated by cell-in-cell structures. Cell Res 25:785–800CrossRefGoogle Scholar
  32. Overholtzer M, Mailleux AA, Mouneimne G, Normand G, Schnitt SJ, King RW, Cibas ES, Brugge JS (2007) A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 131:966–979CrossRefGoogle Scholar
  33. Pereira ER, Frudd K, Awad W, Hendershot LM (2014) Endoplasmic reticulum (er) stress and hypoxia response pathways interact to potentiate hypoxia-inducible factor 1 (hif-1) transcriptional activity on targets like vascular endothelial growth factor (vegf). J Biol Chem 289:3352–3364CrossRefGoogle Scholar
  34. Queiroz DM, Rocha AM, Melo FF, Rocha GA, Teixeira KN, Carvalho SD, Bittencourt PF, Castro LP, Crabtree JE (2013) Increased gastric il-1beta concentration and iron deficiency parameters in h. Pylori infected children. PLoS One 8:e57420CrossRefGoogle Scholar
  35. Savitri E, Haryana MS (2015) Expression of interleukin-8, interleukin-10 and epstein-barr viral-load as prognostic indicator in nasopharyngeal carcinoma. Glob J Health Sci 7:364–372CrossRefGoogle Scholar
  36. Shannon-Lowe CD, Neuhierl B, Baldwin G, Rickinson AB, Delecluse HJ (2006) Resting b cells as a transfer vehicle for epstein-barr virus infection of epithelial cells. Proc Natl Acad Sci USA 103:7065–7070CrossRefGoogle Scholar
  37. Shinozaki-Ushiku A, Kunita A, Fukayama M (2015) Update on epstein-barr virus and gastric cancer (review). Int J Oncol 46:1421–1434CrossRefGoogle Scholar
  38. Sokolova O, Naumann M (2017) NF-kappaB signaling in gastric cancer. Toxins (Basel) 9:119CrossRefGoogle Scholar
  39. Takada K, Horinouchi K, Ono Y, Aya T, Osato T, Takahashi M, Hayasaka S (1991) An epstein-barr virus-producer line akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5:147–156CrossRefGoogle Scholar
  40. Tao Y, Shi Y, Jia J, Jiang Y, Yang L, Cao Y (2015) Novel roles and therapeutic targets of epstein-barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma. Expert Rev Mol Med 17:e15CrossRefGoogle Scholar
  41. Temple RM, Zhu J, Budgeon L, Christensen ND, Meyers C, Sample CE (2014) Efficient replication of epstein-barr virus in stratified epithelium in vitro. Proc Natl Acad Sci USA 111:16544–16549CrossRefGoogle Scholar
  42. Tsao SW, Tsang CM (2017) Epstein-barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc Lond B Biol Sci 372:20160270Google Scholar
  43. Tsurumi T, Fujita M, Kudoh A (2005) Latent and lytic epstein-barr virus replication strategies. Rev Med Virol 15:3–15CrossRefGoogle Scholar
  44. Tu C, Zeng Z, Qi P, Li X, Yu Z, Guo C, Xiong F, Xiang B, Zhou M, Gong Z, Liao Q, Yu J, He Y, Zhang W, Li X, Li Y, Li G, Xiong W (2017) Genome-wide analysis of 18 epstein-barr viruses isolated from primary nasopharyngeal carcinoma biopsy specimens. J Virol 91Google Scholar
  45. Yao HL, Song J, Sun P, Song QQ, Sheng LJ, Chi MM, Han J (2016) Gene expression analysis during recovery process indicates the mechanism for innate immune injury and repair from coxsackievirus b3-induced myocarditis. Virus Res 213:314–321CrossRefGoogle Scholar
  46. Yin Y, Si X, Gao Y, Gao L, Wang J (2013) The nuclear factor-kappab correlates with increased expression of interleukin-6 and promotes progression of gastric carcinoma. Oncol Rep 29:34–38CrossRefGoogle Scholar
  47. Young LS, Rickinson AB (2004) Epstein-barr virus: 40 years on. Nat Rev Cancer 4:757–768CrossRefGoogle Scholar
  48. Yu Z, Lu J, Yu H, Yan Q, Zuo L, Li G (2011) A precise excision of the complete epstein-barr virus genome in a plasmid based on a bacterial artificial chromosome. J Virol Methods 176:103–107CrossRefGoogle Scholar
  49. Yu H, Lu J, Zuo L, Yan Q, Yu Z, Li X, Huang J, Zhao L, Tang H, Luo Z, Liao Q, Zeng Z, Zhang J, Li G (2012) Epstein-barr virus downregulates microrna 203 through the oncoprotein latent membrane protein 1: a contribution to increased tumor incidence in epithelial cells. J Virol 86:3088–3099CrossRefGoogle Scholar
  50. Zhang G, Tsang CM, Deng W, Yip YL, Lui VW, Wong SC, Cheung AL, Hau PM, Zeng M, Lung ML, Chen H, Lo KW, Takada K, Tsao SW (2013) Enhanced il-6/il-6r signaling promotes growth and malignant properties in EBV-infected premalignant and cancerous nasopharyngeal epithelial cells. PLoS ONE 8:e62284CrossRefGoogle Scholar
  51. Zhang H, Li Y, Wang HB, Zhang A, Chen ML, Fang ZX, Dong XD, Li SB, Du Y, Xiong D, He JY, Li MZ, Liu YM, Zhou AJ, Zhong Q, Zeng YX, Kieff E, Zhang Z, Gewurz BE, Zhao B, Zeng MS (2018) Ephrin receptor a2 is an epithelial cell receptor for epstein-barr virus entry. Nat Microbiol 3:1–8CrossRefGoogle Scholar
  52. Zhao G, Zhu G, Huang Y, Zheng W, Hua J, Yang S, Zhuang J, Ye J (2016) Il-6 mediates the signal pathway of jak-stat3-vegf-c promoting growth, invasion and lymphangiogenesis in gastric cancer. Oncol Rep 35:1787–1795CrossRefGoogle Scholar
  53. Zheng Y, Qin Z, Ye Q, Chen P, Wang Z, Yan Q, Luo Z, Liu X, Zhou Y, Xiong W, Ma J, Li G (2014) Lactoferrin suppresses the epstein-barr virus-induced inflammatory response by interfering with pattern recognition of tlr2 and tlr9. Lab Invest 94:1188–1199CrossRefGoogle Scholar
  54. Zhu C, Wu Y, Chen S, Yu M, Zeng Y, You X, Xiao J, Wang S (2012) Protective immune responses in mice induced by intramuscular and intranasal immunization with a mycoplasma pneumoniae p1c DNA vaccine. Can J Microbiol 58:644–652CrossRefGoogle Scholar
  55. Zuo L, Yue W, Du S, Xin S, Zhang J, Liu L, Li G, Lu J (2017a) An update: epstein-barr virus and immune evasion via microrna regulation. Virol Sin 32:175–187CrossRefGoogle Scholar
  56. Zuo LL, Zhang J, Liu LZ, Zhou Q, Du SJ, Xin SY, Ning ZP, Yang J, Yu HB, Yue WX, Wang J, Zhu FX, Li GY, Lu JH (2017b) Cadherin 6 is activated by epstein-barr virus lmp1 to mediate emt and metastasis as an interplay node of multiple pathways in nasopharyngeal carcinoma. Oncogenesis 6:402CrossRefGoogle Scholar

Copyright information

© Wuhan Institute of Virology, CAS 2019

Authors and Affiliations

  1. 1.NHC Key Laboratory of Carcinogenesis, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of EducationXiangya Hospital, Central South UniversityChangshaChina
  2. 2.Department of Microbiology, School of Basic Medical ScienceCentral South UniversityChangshaChina
  3. 3.Department of Biological ScienceFlorida State UniversityTallahasseeUSA

Personalised recommendations